Sensory gating deficits in schizophrenia: Can we parse the effects of medication, nicotine use, and changes in clinical status

Clinical Neuroscience Research

Volumn 3, Issue 1-2, 2003, Pages 47-54

  Light, Gregory A ^a   Braff, David L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gating; Medications effects; P50; Potential suppression and prepulse inhibition; Schizophrenia; Suppression

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; NICOTINE; NICOTINIC AGENT; PROTEIN P50;

ATTENTION; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVENT RELATED POTENTIAL; HUMAN; INFORMATION PROCESSING; INHIBITION KINETICS; MEDICAL ASSESSMENT; MEDICAL RESEARCH; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REVIEW; SCHIZOPHRENIA; SELF REPORT; SENSORY SYSTEM; STARTLE REFLEX; STIMULUS RESPONSE;

EID: 0042531548     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(03)00018-5     Document Type: Review

References (103)

1. Bleuler E. Dementia praecox; or the group of schizophrenias 1911/1952 International Universities Press New York
2. Kraepelin E. Robertson G.M. Dementia praecox and paraphrenia 1919 Livingstone Edinburgh
3. McGhie A. Chapman J. Disorders of attention and perception in early schizophrenia Br J Med Psychol 34 1961 103-116
4. Venables P. Input dysfunction in schizophrenia Prog Exper Pers Res 1 1964 1-47
5. Braff D.L. Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies Arch Gen Psychiatry 47 2 1990 181-188
6. Light G.A. Braff D.L. Clinical and electrophysiological correlates of experiences of perceptual anomalies in schizophrenia patients 2002 Society for Biological Psychiatry Philadelphia, PA
7. Braff DL, Freedman R. Endophenotypes in studies of the genetics of schizophrenia. In: ACNP 5th Generation of Progress, in press.
8. Braff D.L. Psychophysiological and information processing approaches to schizophrenia In: Charney D.S. Nestler E. Bunney B.S. (Eds.) Neurobiological foundation of mental illness 1999 258-271 Oxford University Press New York
9. Freedman R. Adler L.E. Gerhardt G.A. et al. Neurobiological studies of sensory gating in schizophrenia Schizophr Bull 13 4 1987 669-678
10. Freedman R. Waldo M. Bickford-Wimer P. Nagamoto H. Elementary neuronal dysfunctions in schizophrenia Schizophr Res 4 2 1991 233-243
11. Light G.A. Braff D.L. Human and animal models of schizophrenia-related gating deficits Curr Psychiatry Rep 1 1 1999 31-41
12. Bunney W.E.Jr Hetrick W.P. Bunney B.G. et al. Structured Interview for Assessing Perceptual Anomalies (SIAPA) Schizophr Bull 25 3 1999 577-592
13. Brown C. Cromwell R.L. Filion D. Dunn W. Tollefson N. Sensory processing in schizophrenia: missing and avoiding information Schizophr Res 55 1-2 2002 187-195
14. Hetrick W.P. Sensory gating: construct definition, development of a self-report rating instrument, and comparison with a psychophysiological measure Psychology 1999 The Ohio State University Ohio
15. Adler L.E. Pachtman E. Franks R.D. Pecevich M. Waldo M.C. Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia Biol Psychiatry 17 6 1982 639-654
16. Light G.A. Malaspina D. Geyer M.A. et al. Amphetamine disrupts P50 suppression in normal subjects Biol Psychiatry 46 7 1999 990-996
17. Erwin R.J. Turetsky B.I. Moberg P. Gur R.C. Gur R.E. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention Schizophr Res 33 3 1998 157-167
18. Jin Y. Potkin S.G. Patterson J.V. Sandman C.A. Hetrick W.P. Bunney W.E.Jr Effects of P50 temporal variability on sensory gating in schizophrenia Psychiatry Res 70 2 1997 71-81
19. Olincy A. Ross R.G. Harris J.G. et al. The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia Biol Psychiatry 47 11 2000 969-977
20. Braff D.L. Stone C. Callaway E. Geyer M.A. Glick I. Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics Psychophysiology 15 4 1978 339-343
21. Braff D.L. Geyer M.A. Light G.A. et al. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia Schizophr Res 49 1-2 2001 171-178
22. Cadenhead K.S. Swerdlow N.R. Shafer K.M. Diaz M. Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypical personality disorder: evidence of inhibitory deficits An. J. Psychiatry 4 2000 1660-1668
23. Kumari V. Soni W. Mathew V.M. Sharma T. Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication Arch Gen Psychiatry 57 6 2000 609-614
24. Freedman R. Leonard S. Olincy A. et al. Evidence for the multigenic inheritance of schizophrenia Am J Med Genet 105 8 2001 794-800
25. Freedman R. Adler L.E. Olincy A. et al. Input dysfunction, schizotypy, and genetic models of schizophrenia Schizophr Res 54 1-2 2002 25-32
26. Cadenhead K.S. Light G.A. Geyer M.A. McDowell J.E. Braff D.L. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? Am J Psychiatry 159 5 2002 869-871
27. Light G.A. Braff D.L. Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? Biol Psychiatry 47 5 2000 463-467
28. Light G.A. Braff D.L. Unawareness of illness in schizophrenia: the importance of diagnostic subtype, symptoms, and neuropsychological functioning Biol Psychiatry 51 2002 245
29. Amador X.F. Flaum M. Andreasen N.C. et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders Arch Gen Psychiatry 51 10 1994 826-836
30. Arango C. Adami H. Sherr J.D. Thaker G.K. Carpenter W.T.Jr Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness Am J Psychiatry 156 7 1999 1097-1099
31. Laroi F. Fannemel M. Ronneberg U. et al. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests Psychiatry Res 100 1 2000 49-58
32. Young D.A. Davila R. Scher H. Unawareness of illness and neuropsychological performance in chronic schizophrenia Schizophr Res 10 2 1993 117-124
33. Pini S. Cassano G.B. Dell'Osso L. Amador X.F. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features Am J Psychiatry 158 1 2001 122-125
34. Adler L.E. Hoffer L.D. Wiser A. Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am J Psychiatry 150 12 1993 1856-1861
35. Boutros N.N. Zouridakis G. Overall J. Replication and extension of P50 findings in schizophrenia Clin Electroenceph 22 1 1991 40-45
36. Clementz B.A. Geyer M.A. Braff D.L. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects Schizophr Res 30 1 1998 71-80
37. Judd L.L. McAdams L. Budnick B. Braff D.L. Sensory gating deficits in schizophrenia: new results Am J Psychiatry 149 4 1992 488-493
38. Adler L. Ross R. Nagamoto H. Cawthra E. Olincy A. McRae K. Olanzapine's effect on auditory sensory gating Biol Psychiatry 45 8S 1999 35S
39. Light G.A. Geyer M.A. Clementz B.A. Cadenhead K.S. Braff D.L. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications Am J Psychiatry 157 5 2000 767-771
40. Nagamoto H.T. Adler L.E. Hea R.A. Griffith J.M. McRae K.A. Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine Biol Psychiatry 40 3 1996 181-188
41. Nagamoto H.T. Adler L.E. McRae K.A. et al. Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol Neuropsychobiology 39 1 1999 10-17
42. Yee C.M. Nuechterlein K.H. Morris S.E. White P.M. P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects J Abnorm Psychol 107 4 1998 691-698
43. Braff D.L. Geyer M.A. Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology (Berl) 156 2-3 2001 234-258
44. Geyer M.A. Krebs-Thomson K. Braff D.L. Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology (Berl) 156 2-3 2001 117-154
45. Swerdlow N.R. Geyer M.A. Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges Psychopharmacology (Berl) 156 2-3 2001 194-215
46. Coles M.G.H. Donchin E. Porges S.W. Psychophysiology: systems, processes, and applications 1986 Guilford Press New York
47. Biacabe B. Chevallier J.M. Avan P. Bonfils P. Functional anatomy of auditory brainstem nuclei: application to the anatomical basis of brainstem auditory evoked potentials Auris Nasus Larynx 28 1 2001 85-94
48. Freedman R. Adler L.E. Waldo M.C. Pachtman E. Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients Biol Psychiatry 18 5 1983 537-551
49. Davis H. Mast T. Yoshie N. Zerlin S. The slow response of the human cortex to auditory stimuli: recovery process Electroenceph clin Neurophysiol 21 2 1966 105-113
50. Grillon C. Ameli R. Braff D.L. Middle latency auditory evoked potentials (MAEPs) in chronic schizophrenics Schizophr Res 5 1 1991 61-66
51. Fein G. Biggins C. van Dyke C. The auditory P50 response is normal in Alzheimer's disease when measured via a paired click paradigm Electroenceph clin Neurophysiol 92 6 1994 536-545
52. Jessen F. Kucharski C. Fries T. et al. Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease Am J Psychiatry 158 8 2001 1319-1321
53. Boutros N.N. Overall J. Zouridakis G. Test-retest reliability of the P50 mid-latency auditory evoked response Psychiatry Res 39 2 1991 181-192
54. Cadenhead K.S. Light G.A. Geyer M.A. Braff D.L. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder Am J Psychiatry 157 1 2000 55-59
55. Cardenas V.A. Gerson J. Fein G. The reliability of P50 suppression as measured by the conditioning/testing ratio is vastly improved by dipole modeling Biol Psychiatry 33 5 1993 335-344
56. Clementz B.A. Geyer M.A. Braff D.L. P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis Biol Psychiatry 41 10 1997 1035-1044
57. Erwin R.J. Mawhinney-Hee M. Gur R.C. Gur R.E. Midlatency auditory evoked responses in schizophrenia Biol Psychiatry 30 5 1991 430-442
58. Guterman Y. Josiassen R.C. Bashore T.R.Jr Attentional influence on the P50 component of the auditory event- related brain potential Int J Psychophysiol 12 2 1992 197-209
59. Hetrick W.P. Sandman C.A. Bunney W.E.Jr Yin Y. Potkin S.G. White M.H. Gender differences in gating of the auditory evoked potential in normal subjects Biol Psychiatry 39 1 1996 51-58
60. Jerger K. Biggins C. Fein G. P50 suppression is not affected by attentional manipulations Biol Psychiatry 31 4 1992 365-377
61. Schwarzkopf S.B. Lamberti J.S. Smith D.A. Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition Biol Psychiatry 33 11-12 1993 815-828
62. Landis C. Hunt W. The startle pattern 1939 Farrar and Rinehart New York, NY
63. Meincke U, Light GA, Geyer MA, Braff DL. On the waveform of the acoustic startle blink in the paradigm of prepulse inhibition: Methodological and physiological aspects. In submission.
64. Oranje B. van Berckel B.N. Kemner C. van Ree J.M. Kahn R.S. Verbaten M.N. P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study Biol Psychiatry 45 7 1999 883-890
65. Braff D.L. Light G.A. Perry W. Cadenhead K.S. Swerdlow N.R. Geyer M.A. Divergence of prepulse inhibition, startle habituation, and P50 gating deficits in schizophrenia patients 2001 American College of Neuropsychopharmacology Hawaii
66. de Bruin N.M. Ellenbroek B.A. Cools A.R. Coenen A.M. van Luijtelaar E.L. Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats Psychopharmacology (Berl) 142 1 1999 9-17
67. Adler L.E. Olincy A. Waldo M. et al. Schizophrenia, sensory gating, and nicotinic receptors Schizophr Bull 24 2 1998 189-202
68. Cadenhead K.S. Geyer M.A. Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder Am J Psychiatry 150 12 1993 1862-1867
69. Siegel C. Waldo M. Mizner G. Adler L.E. Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses Arch Gen Psychiatry 41 6 1984 607-612
70. Waldo M.C. Adler L.E. Freedman R. Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics Schizophr Res 1 1 1988 19-24
71. Waldo M.C. Carey G. Myles-Worsley M. et al. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families Psychiatry Res 39 3 1991 257-268
72. Adler L.E. Hoffer L.J. Griffith J. Waldo M.C. Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics Biol Psychiatry 32 7 1992 607-616
73. Clementz B.A. Geyer M.A. Braff D.L. Poor P50 suppression among schizophrenia patients and their first- degree biological relatives Am J Psychiatry 155 12 1998 1691-1694
74. Braff D.L. Freedman R. The importance of endophenotypes in studies of the genetics of schizophrenia In: Davis K.L. Charney D. Coyle J.T. Nemeroff C. (Eds.) ACNP 5th generation of progress 2002 703-716 Lippincott, Williams and Wilkins Baltimore, MD
75. Dalack G.W. Healy D.J. Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings Am J Psychiatry 155 11 1998 1490-1501
76. Waldo M.C. Cawthra E. Adler L.E. et al. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings Schizophr Res 12 2 1994 93-106
77. Kumari V. Checkley S.A. Gray J.A. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers Psychopharmacology (Berl) 128 1 1996 54-60
78. Kumari V. Cotter P.A. Checkley S.A. Gray J.A. Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers Psychopharmacology (Berl) 132 4 1997 389-395
79. Della Casa V. Hofer I. Weiner I. Feldon J. The effects of smoking on acoustic prepulse inhibition in healthy men and women Psychopharmacology (Berl) 137 4 1998 362-368
80. Freedman R. Coon H. Myles-Worsley M. et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc Natl Acad Sci USA 94 2 1997 587-592
81. Leonard S. Gault J. Moore T. et al. Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative Am J Med Genet 81 4 1998 308-312
82. Myles-Worsley M. Coon H. McDowell J. et al. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families Am J Med Genet 88 5 1999 544-550
83. Freedman R. Leonard S. Gault J.M. et al. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7) Am J Med Genet 105 1 2001 20-22
84. Lohr J.B. Braff D.L. On the value of using the term 'second generation' for recently introduced antipsychotic medications Am J Psychiatry 2003 in press
85. Hamm A.O. Weike A.I. Schupp H.T. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues Psychopharmacology (Berl) 156 2-3 2001 259-265
86. Franks R.D. Adler L.E. Waldo M.C. Alpert J. Freedman R. Neurophysiological studies of sensory gating in mania: comparison with schizophrenia Biol Psychiatry 18 9 1983 989-1005
87. Baker N. Adler L.E. Franks R.D. et al. Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses Biol Psychiatry 22 5 1987 603-617
88. Adler L.E. Gerhardt G.A. Franks R. et al. Sensory physiology and catecholamines in schizophrenia and mania Psychiatry Res 31 3 1990 297-309
89. Baker N.J. Staunton M. Adler L.E. et al. Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups Biol Psychiatry 27 5 1990 519-528
90. Perry W. Minassian A. Feifel D. Braff D.L. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania Biol Psychiatry 50 6 2001 418-424
91. Weike A.I. Bauer U. Hamm A.O. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients Biol Psychiatry 47 1 2000 61-70
92. Parwani A. Duncan E.J. Bartlett E. et al. Impaired prepulse inhibition of acoustic startle in schizophrenia Biol Psychiatry 47 7 2000 662-669
93. Pappadopulos E. Jensen P.S. Schur S.B. et al. 'Real world' atypical antipsychotic prescribing practices in public child and adolescent inpatient settings Schizophr Bull 28 1 2002 111-121
94. Miller A.L. Craig C.S. Combination antipsychotics: pros, cons, and questions Schizophr Bull 28 1 2002 105-109
95. Clark R.E. Bartels S.J. Mellman T.A. Peacock W.J. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy Schizophr Bull 28 1 2002 75-84
96. Weissman E.M. Antipsychotic prescribing practices in the Veterans Healthcare Administration-New York metropolitan region Schizophr Bull 28 1 2002 31-42
97. Essock S.M. Editor's introduction: antipsychotic prescribing practices Schizophr Bull 28 1 2002 1-4
98. Adler L.E. Freedman R. Ross R.G. Olincy A. Waldo M.C. Elementary phenotypes in the neurobiological and genetic study of schizophrenia Biol Psychiatry 46 1 1999 8-18
99. Leumann L. Feldon J. Vollenweider F.X. Ludewig K. Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia Biol Psychiatry 52 7 2002 729-739
100. Kumari V. Soni W. Sharma T. Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics Schizophr Res 55 1-2 2002 139-146
101. Kumari V. Soni W. Sharma T. Normalization of information processing deficits in schizophrenia with clozapine Am J Psychiatry 156 7 1999 1046-1051
102. Clementz B.A. Blumenfeld L.D. Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia Exp Brain Res 139 4 2001 377-390
103. Perry W. Feifel D. Minassian A. Bhattacharjie I. Braff D.L. Information processing deficits in medicated and not currently medicated acutely psychotic schizophrenia patients Am J Psychiatry 159 8 2002 1375-1381